Skip to main content
. 2025 Apr 16;25:215. doi: 10.1186/s12886-025-04045-4

Table 3.

The injection rate, VAS, IOP difference and anxiety score distribution of the two anti-VEGF agents, with P values

Ranibizumab
(N = 35 (41.7%)
Bevacizumab
(N = 49(58.3%)
p
Injection rate (sec) 2.09 ± 0.32(1.45–2.41) 1.93 ± 0.40(1.07–2.49) 0.066
VAS 2.63 ± 1.11(1–5) 3.69 ± 1.75 (1–8) 0.005
Anxiety Score 7.54 ± 3.95(2–16) 9.96 ± 5.89(1–26) 0.063
Postop-preop IOP difference (mmHg) 7.23 ± 4.91(2–21) 7.29 ± 4.02(1–21) 0.526

VAS: Visual Analogue Scale, IOP: Intraocular pressure